Navigation Links
The Data Surrounding the Legal Cannabis Markets
Date:3/17/2017

NEW YORK, March 17, 2017 /PRNewswire/ --

FinancialBuzz.com News Commentary 

In a recent report by Arcview Market Research, the legal cannabis market is arguably the fastest growing industry in the world. The data reported shows, that regulated cannabis sales in North America totaled $6.9 billion in 2016, a 30 percent increase from 2015. Sales are projected to increase to $21.6 billion by the year 2021, representing a 26 percent compound annual growth rate. In Colorado, Washington, and Oregon, where cannabis products for recreational use were legalized before 2016, consumers spending on cannabis were up 62% between 2015 and September 2016. ChineseInvestors.com, Inc. (OTC: CIIX), 22nd Century Group Inc. (NYSE: XXII), Medical Marijuana Inc. (OTC: MJNA), OWC Pharmaceuticals (OTC: OWCP), Through Terra Tech Corporation (OTC: TRTC)

As a result of the industry's growth, experts now expect a shift from sales on the black market, to gain steam in the legal cannabis market. "It's one of the major reasons that people are going to leave the underground market to go to the aboveground market. It's about variety," Arcview CEO Troy Dayton told Business Insider. "You just can't get these products on the underground market."

ChineseInvestors.com, Inc. (OTCQB: CIIX) on February 1st announced, the launch of its new website for its new subsidiary ChineseCBDoil.com. The website went live on January 31st, under the URL: http://www.ChineseCBDoil.com.

The Company is expanding into the medical marijuana industry with the launch of its website, and plans to retail hemp oil and related products, which are legal to sell and distribute within China, and in the United States, in all fifty states (hemp oil is not marijuana, but indeed a separate and distinct plant made from hemp). CBD oil, derived from hemp is a product with medicinal qualities that are primarily used for anti-inflammatory and other common ailments.

Mr. Warren Wang, the Chairman of ChineseInvestors.com stated: "I am very pleased to see the investor reaction to our announced plans which we began to disclose over a month ago. Indeed the market has responded with very strong interest in our shares, and as a result, we have achieved record trading volume and reached a new fifty-two week high in our shares last week."

Plant biotechnology company, 22nd Century Group Inc. (NYSE: XXII), is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants, through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties, development of X-22, a smoking cessation aid consisting of very low nicotine cigarettes, manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes, production of SPECTRUM research cigarettes for the National Institute on Drug Abuse; contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol, plants with high levels of cannabidiol, and other non-THC cannabinoids.

Development-stage company that operates in the cannabis and industrial hemp space in America, Medical Marijuana Inc. (OTCQB: MJNA), announced that its subsidiary HempMeds® Mexico, had held a press conference in Mexico, to reveal the positive results of a recent study conducted by renowned Mexican physician, Dr. Saul Garza Morales, on the effects of the Company's Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy. The study, conducted by Mexican pediatric neurologist Dr. Garza, included 39 patients with Lennox-Gastaut syndrome, a severe form of pediatric epilepsy that typically develops before the age of four. Of those 39 patients, which took up to 5-7mg CBD/kg progressive doses of RSHO-X™ 5000MG, 84% experienced reduction in motor seizures; 53% reported better than a 75% reduction in seizures; and 7 reported a complete elimination of all seizures, over a 4-month period, with zero reported side effects.

OWC Pharmaceuticals (OTCQB: OWCP) is focused on the development of two delivery systems: A proprietary, cannabinoid-enriched sublingual tablet and a proprietary topical compound. The company developed its cannabinoid-enriched sublingual tablet for the administration of medical cannabis, near the end of last year. The tablet was developed to increase the bioavailability of cannabinoids and provide an optimal administration method for consistent dosing. The company plans to develop the tablet to treat conditions like multiple myeloma, post-traumatic stress disorder, and fibromyalgia. OWC Pharmaceuticals formulated a topical cannabinoid-based cream for the treatment of psoriasis, in partnership with Emilia Cosmetics Ltd., one of Israel's largest cosmetic manufacturers.

Through Terra Tech Corporation (OTCQX: TRTC) together with its subsidiaries, engages in the design, marketing, and sale of hydroponic equipment with proprietary technology, to create sustainable solutions for the cultivation of indoor agriculture in Newport Beach and Irvine, California. It operates through two segments: Hydroponic Produce and Cannabis Products. It also operates as a retail seller of hydroponic produce, herbs, and floral products, which are distributed in the Midwest and the Northeast United States; and produces and sells a line of cannabis flowers and cigarettes, as well as a line of cannabis pure concentrates, including oils, waxes, shatters, and clears to dispensaries in California.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news. FinancialBuzz.com only regurgitates financial or corporate news through our unique financial newswire and media platform. We also do not include any personal opinions or commentary. For this release, FinancialBuzz.com has been compensated three thousand dollars for financial news dissemination and pr services by chineseInvestors.com inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com has signed a two year agreement with chineseinvestors.com inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information:
Media Contact:
E-mail: info@financialbuzz.com
Phone: +1-877-601-1879

URL: http://www.FinancialBuzz.com


'/>"/>
SOURCE FinancialBuzz.com
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Platelets modulate clotting behavior by feeling their surroundings
2. Author Tory Williams Sets Out To Engage The Public And Combat The Controversy Surrounding Stem Cell Therapy With Informative New Book
3. Save The Cord Foundation, a Global Leader in Cord Blood Advocacy, Announces its Expansion of Educational Information Surrounding Other Non-Controversial Stem Cell Sources
4. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
5. FDASmart Inc.’s Breach of Contract Lawsuit Against Dishman USA Survives Appeal, India-based Dishman’s New Jersey Subsidiary Legally Bound in Upcoming Trial by Jury
6. Cannavoices Launches a Legal Medical Cannabis Documentary Initiative
7. China Cord Blood Corporations Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal
8. First Harvest Financial Provides Assistance and Advice to Startups in the Legal Medical Cannabis Industry
9. Primetime Legal Services Agency Enters Agreement to Represent Trial Expert Dr. Ernest Chiodo
10. Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer
11. NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... ... April 20, 2017 , ... ... scientific and clinical research community’s growing body of knowledge during its Eighth ... Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, ...
(Date:4/20/2017)... , April 20, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: ... results at the International Liver Congress ("ILC") 2017 of the ... Amsterdam on the positive effects of ... model of obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, Vice-President of R&D ...
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the leader in ... today that they were named one of the 2017 Top 10 eClinical Trial ... in the pharmaceutical industry. , “We take pride in honoring Parallel6 as one of ...
(Date:4/20/2017)... Dutch philosopher Koert van Mensvoort - founder of the Next Nature Network ... - has written a ,Letter to Humanity, in support of International ... a slave and victim to its own technology, but to employ technology to ... ... – founder of the Next Nature Network and Fellow of ‘Next Nature’ at ...
Breaking Biology Technology:
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology , ... recognition technologies, today announced the release of the ... which provides improved facial recognition using up to ... a single computer. The new version uses deep ... accuracy, and it utilizes a Graphing Processing Unit ...
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. ... Used combined in one project, multi-biometric solutions ... ...
Breaking Biology News(10 mins):